SCHEMBL9878759

SCHEMBL9878759

Clc1nc(C2CC2)nc2c1SCCC2

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 12/20 0.43
▸ NR1I2 O75469 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23586251 0.95 PDE10A (0.38) PDE10A
SCHEMBL9879791 0.80 — —
SCHEMBL7389179 0.77 TNKS (0.33) —
SCHEMBL15661120 0.75 — —
SCHEMBL9384614 0.74 TNKS (0.31) —
SCHEMBL11035315 0.74 KDM4E (0.35) —
SCHEMBL9382612 0.72 PDE10A (0.49) PDE10A
SCHEMBL30095928 0.72 PDE10A (0.48) PDE10A
SCHEMBL30095835 0.72 PDE10A (0.48) PDE10A
Hydrochloric Acid SCHEMBL9382876 0.70 PDE10A (0.47) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994464-A Treatment of elevated intraocular pressure and glaucoma MERCK & CO., INC. (US) 1991-02-19 — — US disclosed
US-4889856-A INTRAOCULAR PRESSURE REDUCTION; CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1989-12-26 — — US disclosed
EP-0276057-A2 Piperazinylpyrimidines as beta-adrenergic receptor blocking agents MERCK & CO. INC. (US) 1988-07-27 — — EP disclosed
Send feedback